The immune system normally identifies and eliminates cancer cells prior to tumor formation. However, cancer cells can induce inhibitory mechanisms that limit antitumor immune activity, allowing for disease progression. In this webinar brought to you by The Scientist and Bio-Techne, Dario Vignali and Peter Westcott will discuss the tug-of-war between cancer cells and the immune system, how cancer cells evade immune cells, and what can be done to circumvent or attenuate these mechanisms for therapeutic purposes.
Topics to be covered
Understanding immune inhibitory mechanisms in cancer
Modeling T-cell dysfunction in colon cancer
Monday, January 10, 2022
2:30 - 4:00 PM Eastern Time
Meet the speakers
Dario A. Vignali, PhD Frank Dixon Chair in Cancer Immunology Vice Chair and Distinguished Professor of Immunology Director, Cancer Immunology Training Program Department of Immunology, School of Medicine University of Pittsburgh
Peter Westcott, PhD Postdoctoral Scientist
David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology
Sponsored by
Register
TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
